Improving Care for Older Adults with Cancer in Canada: A Call to Action
- PMID: 39057151
- PMCID: PMC11275828
- DOI: 10.3390/curroncol31070279
Improving Care for Older Adults with Cancer in Canada: A Call to Action
Abstract
Most patients diagnosed with and dying from cancer in Canada are older adults, with aging contributing to the large projected growth in cancer incidence. Older adults with cancer have unique needs, and on a global scale increasing efforts have been made to address recognized gaps in their cancer care. However, in Canada, geriatric oncology remains a new and developing field. There is increasing recognition of the value of geriatric oncology and there is a growing number of healthcare providers interested in developing the field. While there is an increasing number of dedicated programs in geriatric oncology, they remain limited overall. Developing novel methods to delivery geriatric care in the oncology setting and improving visibility is important. Formal incorporation of a geriatric oncology curriculum into training is critical to both improve knowledge and demonstrate its value to healthcare providers. Although a robust group of dedicated researchers exist, increased collaboration is needed to capitalize on existing expertise. Dedicated funding is critical to promoting clinical programs, research, and training new clinicians and leaders in the field. By addressing challenges and capitalizing on opportunities for improvement, Canada can better meet the unique needs of its aging population with cancer and ultimately improve their outcomes.
Keywords: cancer; geriatric assessment; geriatric oncology; older adults; systemic therapy; toxicity.
Conflict of interest statement
None of the authors have any relationship, financial or otherwise, which influenced the content of this review article. Some authors have advisory relationships with private companies which are described below. These did not impact or contribute in any way to the manuscript. Sarah Cook: None; Shabbir Alibhai: none; Rajin Mehta: none; Marie-France Savard: advisory roles for AstraZeneca, Lilly, Seagen, Roche, Gilead, Novartis, Knight, and Merck; Caroline Mariano: none; Dominique LeBlanc: consultation/advisory roles for AstraZeneca and Novartis and consultation/advisory/speaker roles for Pfizer; Danielle Desautels: consultation/advisory roles for Astrazeneca, Merck, Gilead, Pfizer, and Novartis and speaker fees for Amgen; Xiaofu Zhu: advisory roles for Pfizer, Novartis, Lilly, AstraZeneca, Genomic Health, Apobiologix, Merck, Leo Pharma, Amgen, Taiho Pharma, and Roche and educational support from Taiho Pharma and Novartis; Rossanna Pezo: advisory roles for Pfizer, Novartis, and Lilly; Karen A Gelmon: consultation/advisory roles for AstraZeneca, Pfizer, Novartis, Seagen, Merck, Lilly, Gilead, Celcuity, and City of Hope; Tina Hsu: advisory roles for Pfizer, Knight Therapeutics, Eisai, Ipsen, Mylan, and Apobiologix.
Figures
References
-
- Canadian Cancer Society . Canadian Cancer Statistics, 2015. Canadian Cancer Society; Toronto, ON, Canada: 2015.
-
- 2. Canadian Cancer Statistics Advisory Committee in Collaboration with the Canadian Cancer Society, S.C. 2021. Canadian Cancer Statistics 2021. [(accessed on 13 April 2023)]. Available online: https://www.cancer.ca/Canadian-Cancer-Statistics-2021-EN.
-
- Li D., Sun C.L., Kim H., Soto-Perez-de-Celis E., Chung V., Koczywas M., Fakih M., Chao J., Chien L.C., Charles K., et al. Geriatric Assessment–Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With Cancer. JAMA Oncol. 2021;7:e214158. doi: 10.1001/jamaoncol.2021.4158. - DOI - PMC - PubMed
-
- Mohile S.G., Mohamed M.R., Xu H., Culakova E., Loh K.P., Magnuson A., A Flannery M., Obrecht S., Gilmore N., Ramsdale E., et al. Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): A cluster-randomised study. Lancet. 2021;398:1894–1904. doi: 10.1016/S0140-6736(21)01789-X. - DOI - PMC - PubMed
-
- Lund C.M., Vistisen K.K., Olsen A.P., Bardal P., Schultz M., Dolin T.G., Rønholt F., Johansen J.S., Nielsen D.L. The effect of geriatric intervention in frail older patients receiving chemotherapy for colorectal cancer: A randomised trial (GERICO) Br. J. Cancer. 2021;124:1949–1958. doi: 10.1038/s41416-021-01367-0. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
